ESC Congress 2025 Hot Line & Late-Breaking Science Collection

  • Published:  08 August 2025
  • Likes: 

    Heart Icon

    5

Up Next

ESC Congress 2025 Hot Line & Late-Breaking Science Collection

  • Published:  08 August 2025
  • Likes: 

    Heart Icon

    5

Average (ratings)
No ratings
Your rating
About the episode

Explore ESC 25 Top Trials with Insights from the Thoraxcenter!

 

Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at ESC 2025.

 

In this comprehensive ESC wrap-up, interventional experts examine the most significant trials, providing valuable insights into their impact on current practices and future research directions.

 

00:15 - DOUBLE-CHOICE
04:43 - VANTAGE
07:44 - VICTOR and VICTORIA
11:29 - DIGIT-HF
14:22 - DAPA ACT HF-TIMI 68
16:55 - BETAMI-DANBLOCK and REBOOT-CNIC
22:13 - REFINE-ICD
25:34 - OPTION-STEMI
30:40 - DUAL-ACS
33:05 - NEO-MINDSET
35:58 - TARGET-FIRST
38:54 - OUTREACH
41:50 - FIRE
42:46 - AI-Gatekeeper
45:13 - POTCAST

Overview

Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.

  • Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen.
  • Watch our Wrap-Up series led by Dr Mirvat Alasnag summarising the key take-aways from each day of the congress.
  • For clinical trial data from principal investigators, keep up with Dr Harriette Van Spall's Late-Breaker Discussion series.
  • Our concise, accessible Expert Interviews will focus on the current data and it's impact on clinical practice.
  • Don't miss the Highlights series to stay ahead of the curve in each field.
  • In the Journal Discussions series, authors of ECR Journal explore their special focuses in depth.
     

More from this programme

Faculty Biographies

Joost Daemen

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam. 

Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile
Nicolas M Van Mieghem

Nicolas M Van Mieghem

Full Professor of Interventional Cardiology

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

 

Academic History

Prof. Nicolas M. Van Mieghem completed his medical training at the Catholic University of Leuven (Belgium), where he earned both his medical degree and his specialist degree in cardiology. During his time in Leuven, he developed a strong interest in cardiovascular medicine, particularly in the emerging field of minimally invasive cardiac interventions. After finishing his core medical and cardiology training, he pursued multiple advanced…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.